MX2020007768A - Tratamiento contra hipoglucemia posbariátrica usando pequeñas dosis de glucagón estable. - Google Patents
Tratamiento contra hipoglucemia posbariátrica usando pequeñas dosis de glucagón estable.Info
- Publication number
- MX2020007768A MX2020007768A MX2020007768A MX2020007768A MX2020007768A MX 2020007768 A MX2020007768 A MX 2020007768A MX 2020007768 A MX2020007768 A MX 2020007768A MX 2020007768 A MX2020007768 A MX 2020007768A MX 2020007768 A MX2020007768 A MX 2020007768A
- Authority
- MX
- Mexico
- Prior art keywords
- post
- mini
- treatment
- bariatric hypoglycemia
- bariatric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862620861P | 2018-01-23 | 2018-01-23 | |
| PCT/US2019/014815 WO2019147718A1 (en) | 2018-01-23 | 2019-01-23 | Treatment of post-bariatric hypoglycemia using mini-dose stable glucagon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020007768A true MX2020007768A (es) | 2020-11-12 |
Family
ID=65352189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020007768A MX2020007768A (es) | 2018-01-23 | 2019-01-23 | Tratamiento contra hipoglucemia posbariátrica usando pequeñas dosis de glucagón estable. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210030847A1 (https=) |
| EP (1) | EP3743097A1 (https=) |
| JP (1) | JP7444786B2 (https=) |
| KR (1) | KR20200134213A (https=) |
| CN (1) | CN111936159A (https=) |
| AU (1) | AU2019211352A1 (https=) |
| BR (1) | BR112020014719A2 (https=) |
| MX (1) | MX2020007768A (https=) |
| WO (1) | WO2019147718A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018026899A1 (en) * | 2016-08-03 | 2018-02-08 | Joslin Diabetes Center, Inc. | Methods and compositions for treating hypoglycemia |
| US12543982B2 (en) | 2021-01-22 | 2026-02-10 | Cilag Gmbh International | Method of adjusting a surgical parameter based on biomarker measurements |
| US12569203B2 (en) * | 2021-01-22 | 2026-03-10 | Cilag Gmbh International | Bariatric surgery post-surgical monitoring |
| US12527515B2 (en) | 2021-01-22 | 2026-01-20 | Cilag Gmbh International | Colorectal surgery post-surgical monitoring |
| US12128089B2 (en) * | 2022-05-26 | 2024-10-29 | Slayback Pharma Llc | Stable liquid compositions of glucagon |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2552952A1 (en) | 2010-03-26 | 2013-02-06 | Novo Nordisk A/S | Novel glucagon analogues |
| EP2683364B1 (en) | 2011-03-10 | 2017-01-18 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of peptide drugs |
| JP2014510739A (ja) * | 2011-03-28 | 2014-05-01 | ノヴォ ノルディスク アー／エス | 新規のグルカゴン類似体 |
| AU2013295035B2 (en) * | 2012-07-23 | 2017-08-03 | Zealand Pharma A/S | Glucagon analogues |
| DK3102184T3 (da) | 2014-02-06 | 2019-05-06 | Xeris Pharmaceuticals Inc | Stabile formuleringer af peptider og fremgangsmåder til fremstilling |
| MY185334A (en) * | 2014-12-30 | 2021-05-06 | Hanmi Pharm Ind Co Ltd | Glucagon derivatives with improved stability |
| AU2016267052B2 (en) * | 2015-05-22 | 2022-01-20 | The Bot Of The Leland Stanford Junior University | Treatment of post-bariatric hypoglycemia with GLP-1 antagonists |
| WO2016196976A1 (en) * | 2015-06-04 | 2016-12-08 | Xeris Pharmaceuticals, Inc. | Glucagon delivery apparatuses and related methods |
| US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
| AU2016304588A1 (en) * | 2015-08-06 | 2018-02-15 | Xoma (Us) Llc | Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia |
| GB201710822D0 (en) * | 2017-07-05 | 2017-08-16 | Zealand Pharma As | Methods and medical uses relating to the treatment of hypoglycaemia |
-
2019
- 2019-01-23 BR BR112020014719-2A patent/BR112020014719A2/pt not_active IP Right Cessation
- 2019-01-23 US US16/964,124 patent/US20210030847A1/en not_active Abandoned
- 2019-01-23 JP JP2020561591A patent/JP7444786B2/ja active Active
- 2019-01-23 KR KR1020207022613A patent/KR20200134213A/ko not_active Ceased
- 2019-01-23 CN CN201980009791.5A patent/CN111936159A/zh active Pending
- 2019-01-23 MX MX2020007768A patent/MX2020007768A/es unknown
- 2019-01-23 WO PCT/US2019/014815 patent/WO2019147718A1/en not_active Ceased
- 2019-01-23 AU AU2019211352A patent/AU2019211352A1/en not_active Abandoned
- 2019-01-23 EP EP19704169.2A patent/EP3743097A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021511386A (ja) | 2021-05-06 |
| BR112020014719A2 (pt) | 2020-12-08 |
| WO2019147718A8 (en) | 2020-08-06 |
| AU2019211352A1 (en) | 2020-07-30 |
| EP3743097A1 (en) | 2020-12-02 |
| KR20200134213A (ko) | 2020-12-01 |
| WO2019147718A1 (en) | 2019-08-01 |
| US20210030847A1 (en) | 2021-02-04 |
| CN111936159A (zh) | 2020-11-13 |
| JP7444786B2 (ja) | 2024-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020007768A (es) | Tratamiento contra hipoglucemia posbariátrica usando pequeñas dosis de glucagón estable. | |
| EA201891946A1 (ru) | Коагонисты глюкагона и glp-1 для лечения ожирения | |
| PH12020551427A1 (en) | Epinephrine spray formulations | |
| EA201690905A1 (ru) | Специфические антитела против cd38 для лечения злокачественных новообразований у человека | |
| MX2021000289A (es) | Inhibidores pcsk9 para usarse en el tratamiento de hipercolesterolemia. | |
| BR112018010536A2 (pt) | dispositivo de estimulação muscular elétrica transcutânea para tratamento da ejaculação precoce ou disfunção erétil e metódos de uso respectivos | |
| ZA202406617B (en) | Insulin containing pharmaceutical compositions | |
| EP4623976A3 (en) | Respiratory mask with nasogastric tube path | |
| PH12016500296A1 (en) | Sodium channel modulators for the treatment of pain and diabetes | |
| PH12016502336A1 (en) | A novel formulation of meloxicam | |
| CL2017002031A1 (es) | Formulación en polvo nasal para el tratamiento de hipoglicemia | |
| EA201792209A1 (ru) | Схема введения пропущенных доз инъекционных сложных эфиров палиперидона длительного действия | |
| GEAP201814459A (en) | Medical treatments based on anamorelin | |
| PH12020551018A1 (en) | Oral delivery of glp-1 peptide analogs | |
| MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
| ZA202104786B (en) | Deutetrabenazine for the treatment of dyskinesia in cerebral palsy | |
| EA201992272A1 (ru) | Ацилированное инсулиновое соединение | |
| MX355853B (es) | Composicion oftalmica para el tratamiento de infeccion ocular. | |
| GB2564801A (en) | Implantable scaffolds for treatment of sinusitis | |
| EP4696381A3 (en) | Medicine | |
| TW201642906A (en) | Fixed dose combination for pain relief without edema | |
| MY210133A (en) | Compositions and methods for controlled ovarian stimulation | |
| MX369090B (es) | Sultiame para el tratamiento de apnea del sueño. | |
| EA202190891A1 (ru) | Композиции и способы для контролируемой стимуляции яичников | |
| EA202091744A1 (ru) | Лечение аллергического ринита у субъектов детской возрастной категории с применением комбинации мометазона и олопатадина |